159 related articles for article (PubMed ID: 9094675)
1. Molecular determinants for virulence in coxsackievirus B1 infection.
Rinehart JE; Gómez RM; Roos RP
J Virol; 1997 May; 71(5):3986-91. PubMed ID: 9094675
[TBL] [Abstract][Full Text] [Related]
2. Mutations at nucleotides 573 and 579 within 5'-untranslated region augment the virulence of coxsackievirus B1.
Zhong Z; Li X; Zhao W; Tong L; Liu J; Wu S; Lin L; Zhang Z; Tian Y; Zhang F
Virus Res; 2008 Aug; 135(2):255-9. PubMed ID: 18514346
[TBL] [Abstract][Full Text] [Related]
3. Multiple viral determinants mediate myopathogenicity in coxsackievirus B1-induced chronic inflammatory myopathy.
Tam PE; Weber-Sanders ML; Messner RP
J Virol; 2003 Nov; 77(21):11849-54. PubMed ID: 14557670
[TBL] [Abstract][Full Text] [Related]
4. Molecular determinants of disease in coxsackievirus B1 murine infection.
Cifuente JO; Ferrer MF; Jaquenod de Giusti C; Song WC; Romanowski V; Hafenstein SL; Gómez RM
J Med Virol; 2011 Sep; 83(9):1571-81. PubMed ID: 21739448
[TBL] [Abstract][Full Text] [Related]
5. Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype.
Caggana M; Chan P; Ramsingh A
J Virol; 1993 Aug; 67(8):4797-803. PubMed ID: 8392614
[TBL] [Abstract][Full Text] [Related]
6. Interactions between multiple genetic determinants in the 5' UTR and VP1 capsid control pathogenesis of chronic post-viral myopathy caused by coxsackievirus B1.
Sandager MM; Nugent JL; Schulz WL; Messner RP; Tam PE
Virology; 2008 Mar; 372(1):35-47. PubMed ID: 18029287
[TBL] [Abstract][Full Text] [Related]
7. Sequence analysis of the downstream 5' nontranslated region of seven echoviruses with different neurovirulence phenotypes.
Romero JR; Rotbart HA
J Virol; 1995 Feb; 69(2):1370-5. PubMed ID: 7815524
[TBL] [Abstract][Full Text] [Related]
8. Coxsackievirus-induced chronic inflammatory myopathy: virus variants distinguish between acute cytopathic effects and pathogenesis of chronic disease.
Tam PE; Messner RP
Virology; 1997 Jun; 233(1):199-209. PubMed ID: 9201230
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide sequences important for translation initiation of enterovirus RNA.
Iizuka N; Yonekawa H; Nomoto A
J Virol; 1991 Sep; 65(9):4867-73. PubMed ID: 1651409
[TBL] [Abstract][Full Text] [Related]
10. The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model.
Dunn JJ; Bradrick SS; Chapman NM; Tracy SM; Romero JR
J Infect Dis; 2003 May; 187(10):1552-61. PubMed ID: 12721935
[TBL] [Abstract][Full Text] [Related]
11. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region.
Tu Z; Chapman NM; Hufnagel G; Tracy S; Romero JR; Barry WH; Zhao L; Currey K; Shapiro B
J Virol; 1995 Aug; 69(8):4607-18. PubMed ID: 7609025
[TBL] [Abstract][Full Text] [Related]
12. Mutation variants generated from nonvirulent coxsackievirus B3 acquire virulence phenotypes by active virus replication.
Seo I; Jee Y; Ahn J; Jun EJ; Kim D; Joo CH; Kim YK; Lee H
Intervirology; 2007; 50(6):447-53. PubMed ID: 18268408
[TBL] [Abstract][Full Text] [Related]
13. Genetic determinants of susceptibility to coxsackievirus B1-induced chronic inflammatory myopathy: effects of host background and major histocompatibility complex genes.
Tam PE; Messner RP
J Lab Clin Med; 1996 Sep; 128(3):279-89. PubMed ID: 8783635
[TBL] [Abstract][Full Text] [Related]
14. Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolate.
Lee CK; Kono K; Haas E; Kim KS; Drescher KM; Chapman NM; Tracy S
J Gen Virol; 2005 Jan; 86(Pt 1):197-210. PubMed ID: 15604447
[TBL] [Abstract][Full Text] [Related]
15. A point mutation in the VP4 coding sequence of coxsackievirus B4 influences virulence.
Ramsingh AI; Collins DN
J Virol; 1995 Nov; 69(11):7278-81. PubMed ID: 7474153
[TBL] [Abstract][Full Text] [Related]
16. Evidence suggesting that virulence maps to the P1 region of the coxsackievirus B4 genome.
Ramsingh A; Hixson A; Duceman B; Slack J
J Virol; 1990 Jun; 64(6):3078-81. PubMed ID: 2159563
[TBL] [Abstract][Full Text] [Related]
17. Major alteration in coxsackievirus B3 genomic RNA structure distinguishes a virulent strain from an avirulent strain.
Prusa J; Missak J; Kittrell J; Evans JJ; Tapprich WE
Nucleic Acids Res; 2014 Sep; 42(15):10112-21. PubMed ID: 25074382
[TBL] [Abstract][Full Text] [Related]
18. Specific interactions of HeLa cell proteins with Coxsackievirus B3 RNA: La autoantigen binds differentially to multiple sites within the 5' untranslated region.
Cheung P; Zhang M; Yuan J; Chau D; Yanagawa B; McManus B; Yang D
Virus Res; 2002 Dec; 90(1-2):23-36. PubMed ID: 12457960
[TBL] [Abstract][Full Text] [Related]
19. Identification of candidate sequences that determine virulence in Coxsackievirus B4.
Ramsingh A; Araki H; Bryant S; Hixson A
Virus Res; 1992 May; 23(3):281-92. PubMed ID: 1320798
[TBL] [Abstract][Full Text] [Related]
20. Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice.
Tracy S; Chapman NM; Tu Z
Arch Virol; 1992; 122(3-4):399-409. PubMed ID: 1310000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
